Completed PHASE4 INTERVENTIONAL 4-arm NCT00132821

Impact of Smoking Cessation on Sleep - 5

Impact of Smoking Cessation on Sleep

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Sleep Disorders Tobacco Use Cessation

Interventions Bupropion Placebo Bupropion Placebo transdermal nicotine patch Transdermal Nicotine Patch

Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: Aug 31, 2005 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00132821, this PHASE4 trial focuses on Sleep Disorders and Tobacco Use Cessation and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed · Phase: PHASE2_PHASE3 → PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Menlo Park, United States